These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32885627)

  • 21. New antithrombotic drugs for systemic and local delivery for coronary artery disease.
    Shah PK
    J Interv Cardiol; 1995 Aug; 8(4):427-37. PubMed ID: 10155257
    [No Abstract]   [Full Text] [Related]  

  • 22. Does anticoagulation therapy prevent thrombosis in coronary stent grafts?
    Honda Y; Wakabayashi K; Suzuki T; Suzuki H
    Cardiovasc Interv Ther; 2017 Oct; 32(4):405-408. PubMed ID: 27885511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'.
    Rubboli A; Halperin JL
    Thromb Haemost; 2008 Nov; 100(5):752-3. PubMed ID: 18989515
    [No Abstract]   [Full Text] [Related]  

  • 24. Imaging of left main coronary artery thrombus with CT coronary angiography.
    Berger A; Freeman A
    Heart Lung Circ; 2012 Mar; 21(3):196. PubMed ID: 22474688
    [No Abstract]   [Full Text] [Related]  

  • 25. Anticoagulant and antiplatelet drugs.
    Lincoff AM
    Catheter Cardiovasc Interv; 2001 Dec; 54(4):514-20. PubMed ID: 11747192
    [No Abstract]   [Full Text] [Related]  

  • 26. Stent apposition in late and very late stent thrombosis: the apposing views.
    Tomey MI; Mehran R
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):1066-7. PubMed ID: 24255027
    [No Abstract]   [Full Text] [Related]  

  • 27. Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody.
    Roldán V; Marín F
    Thromb Haemost; 2008 Nov; 100(5):754-5. PubMed ID: 18989516
    [No Abstract]   [Full Text] [Related]  

  • 28. Antiplatelet therapy alone is safe and effective after coronary stenting: observations of a transition in practice.
    Zubaid M; Penn IM; Buller CE; Moscovich MD; Ricci DR; Chauhan A
    Can J Cardiol; 1997 Apr; 13(4):335-40. PubMed ID: 9141964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Two platelet inhibitors after acute coronary syndrome. Many colleagues are not aware of this].
    MMW Fortschr Med; 2002 Mar; 144(13):50. PubMed ID: 12008695
    [No Abstract]   [Full Text] [Related]  

  • 30. Evolving concepts in the pathogenesis and treatment of arterial thrombosis.
    Chesebro JH; Toschi V; Lettino M; Gallo R; Badimon JJ; Fallon JT; Fuster V
    Mt Sinai J Med; 1995 Sep; 62(4):275-86. PubMed ID: 7565850
    [No Abstract]   [Full Text] [Related]  

  • 31. Simultaneous subacute coronary drug-eluting stent thrombosis in two different vessels of a patient with factor V Leiden mutation.
    Eshtehardi P; Eslami M; Moayed DA
    J Cardiovasc Med (Hagerstown); 2008 Apr; 9(4):410-3. PubMed ID: 18334899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Warfarin, aspirin, or both after myocardial infarction.
    Amit G; Ilia R; Zahger D
    N Engl J Med; 2003 Jan; 348(3):256-7; author reply 256-7. PubMed ID: 12530435
    [No Abstract]   [Full Text] [Related]  

  • 33. Coronary stenting (Cordis) without anticoagulation.
    Park SW; Park SJ; Hong MK; Kim JJ; Cho SY; Jang YS; Kim KB; Kim KS; Oh DJ; Oh BH; Kang JC
    Am J Cardiol; 1997 Apr; 79(7):901-4. PubMed ID: 9104903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction. Angiographic results from the PRISM-PLUS trial (Platelet receptor inhibition for ischemic syndrome management in patients limited by unstable signs and symptoms). PRISM-PLUS Investigators.
    Zhao XQ; Théroux P; Snapinn SM; Sax FL
    Circulation; 1999 Oct; 100(15):1609-15. PubMed ID: 10517731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coronary thrombosis.
    Fuster V; Fallon JT; Nemerson Y
    Lancet; 1996 Nov; 348 Suppl 1():s7-10. PubMed ID: 8918520
    [No Abstract]   [Full Text] [Related]  

  • 36. Potential role of oral anticoagulants in the treatment of patients with coronary artery disease: focus on dabigatran.
    Doraiswamy VA; Slepian MJ; Gesheff MG; Tantry US; Gurbel PA
    Expert Rev Cardiovasc Ther; 2013 Sep; 11(9):1259-67. PubMed ID: 23968500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in the Treatment of Stable Coronary Artery Disease and Peripheral Artery Disease.
    Gibler WB
    Crit Pathw Cardiol; 2018 Jun; 17(2):53-68. PubMed ID: 29768312
    [No Abstract]   [Full Text] [Related]  

  • 38. Optical Coherence Tomographic Evaluation of Hyperacute Bivalirudin-Induced Coronary Stent Thrombosis.
    Peñalver JL; Shatila W; Perin E
    Tex Heart Inst J; 2017 Aug; 44(4):266-268. PubMed ID: 28878581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficient tirofiban infusion resulting in resolution of intracoronary thrombus.
    Acar G; Sökmen G; Nacar AB; Tuncer C
    Turk Kardiyol Dern Ars; 2008 Apr; 36(3):197. PubMed ID: 18626216
    [No Abstract]   [Full Text] [Related]  

  • 40. Late thrombosis associated with drug-eluting stents.
    Derghazarian S; Eisenberg MJ
    Am Heart Hosp J; 2005; 3(3):203-4. PubMed ID: 16106143
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.